Pantelakis Securities -Jumbo (OW, TP: €21.0/sh): Embracing excellence

Pantelakis Securities -Jumbo (OW, TP: €21.0/sh): Embracing excellence

Target Corporation (TGT) DEBT

 Target Corporation (TGT) DEBT

Target Corporation (TGT) $ EPS

 

Target Corporation (TGT) NET INCOME $

 Target Corporation (TGT) NET INCOME $

Target Corporation (TGT) REVENUE $

 Target Corporation (TGT) REVENUE $

PYRAMID SHEME

 

CUT THE DAMAGE

 

When you find a crack in the stock market...

Bayer initiates landmark Phase III study program to investigate oral FXIa inhibitor asundexian

 

The OCEANIC program will start with two Phase III studies investigating the efficacy and safety of asundexian in prevention of stroke events in patients with atrial fibrillation as well as patients with a non-cardioembolic ischemic stroke or high-risk transient ischemic attack involving up to 30,000 patients / Bayer drives the development of its FXIa inhibitor, with the goal of offering a potential new class of antithrombotics for improved outcomes for patients using selective coagulation modulation

stock market and butterfly